Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression-A single center retrospective study.

Bernard Sean Regidor Scott Jew Marissa-Skye Goldwater Bethany Marie Beatty Sean Bujarski Adam ElSayed Ryan Danis Susanna Kim Regina Swift Gary Schwartz James R Berenson

Published in: European journal of haematology (2023)

This study shows that the two-drug class combination of ISAdm is an effective and well tolerated treatment option for RRMM patients exhibiting only BP.

Keyphrases

end stage renal disease
ejection fraction
multiple myeloma
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
emergency department
patient reported outcomes
diffuse large b cell lymphoma
combination therapy
patient reported
drug induced
hodgkin lymphoma